Overview
Chinese healthcare platform's Q3 revenue fell 16.7% yr/yr amid strategic business model shift
Company achieved non-GAAP net profitability and positive operating cash flow
Company divested three subsidiaries, transitioning to asset-light model
Outlook
Company plans to build AI-powered transaction platform for pharmaceutical procurement
111 Inc expects asset-light model to strengthen liquidity and profitability
Company sees growth in fulfillment network and supply chain capabilities
Result Drivers
ASSET-LIGHT TRANSITION - Co divested three subsidiaries to shift towards an asset-light model, improving profitability and liquidity
SUPPLY CHAIN ENHANCEMENTS - Ongoing "MANTIANXING" initiative improved supply chain capabilities, increasing GMV and customer count
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | RMB 3 bln | ||
Q3 Adjusted Net Income | RMB 1.1 mln | ||
Q3 Net Income | -RMB 1.50 mln | ||
Q3 Adjusted Income From Operations | RMB 0.2 mln | ||
Q3 Income From Operations | -RMB 2.30 mln | ||
Q3 Operating Expenses | RMB 180.30 mln |
Press Release: ID:nPn3VmmMha
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Comments